(PRESS RELEASE) Extract Labs, a Colorado-based hemp extraction lab, has announced that it is funding cancer research currently being conducted at Colorado State University at the James L. Voss Veterinary Teaching Hospital.
Specifically, researchers at CSU are conducting lab-based research on the impact of CBD against canine glioma, or brain and spinal cancer, cells. The research began in early 2019 to learn how CBD interacts with cancer cells, alone and in combination with a commonly used radiation therapy mechanism.
Cannabidiol or CBD has been shown to possess anti-tumor effects in human and rodent gliomas, and several studies demonstrate a similarity in canine and human gliomas. The initial phase of research is almost complete, and the team at Colorado State University hopes to publish study results within the next year.
“We are proud to be one of the few CBD companies in America currently funding canine cancer research through a university that is world-renowned for its medical care and research,” said Craig Henderson.
Extract Labs, a one-stop destination for a wide range of CBD products, is supplying all of the CBD isolate and oils being used for research in this study. Consumers who purchase Extract Labs products on the company’s website have the opportunity to donate towards the costs of funding the CSU study.
“While this research is in very early stages, we look forward to learning more about the potential impact that CBD has on canine glioma cells,” said Stephanie McGrath, a neurologist at CSU’s veterinary teaching hospital. McGrath is teaming up with Dan Gustafson, professor of pharmacology and biomedical engineering, on this study.